0
0
6/18/23 at 12:00pm
Organization
Business Standard
Author
Business Standard
42 words
0
Comments
Breast cancer medicines known as aromatase inhibitors may diminish the benefit of weight loss therapies, according to a new study presented at ENDO 2023, the Endocrine Society's annual meeting
You are the first to view
https://www.business-standard.com/india-news/breast-cancer-treatments-limit-effects-of-weight-loss-medications-study-123061800573_1.html
Create an account
or login to join the discussion